Regal Assets Analytics

Bill Langbein

Evolus & Urovant: Similar Strategies, Opposite Reactions to Positive Catalysts

By |2019-03-25T11:45:49-04:00March 25th, 2019|Categories: Bill Langbein, Case Study, Education, Healthcare, Insights, Pharmaceutical & Biotechnology|Tags: , , , , |

One of the strongest performing biopharmaceutical stocks this year is [...]

Recro To Consider Dispute Resolution With FDA After Complete Response Letter

By |2019-03-25T11:40:52-04:00March 24th, 2019|Categories: Bill Langbein, Insights, SanaCurrents|Tags: , , , |

Shares of Recro Pharma, Inc. (NASDAQ:REPH) likely will fall in [...]

ADMA New Catalysts For 2019 – Two PDUFA decisions on immunodeficiency therapies

By |2019-01-22T10:10:21-04:00January 22nd, 2019|Categories: Bill Langbein, SanaCurrents, SanaCurrents Probability Sentiment|Tags: , |

SUMMARY SanaCurrents assigns a pivotal sentiment the FDA will approve [...]

Verona (VRNA) Talks Up The Long View Following Phase II Setback

By |2019-03-07T14:59:36-04:00January 16th, 2019|Categories: Bill Langbein, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents|Tags: , , , |

Verona Pharma (NASDAQ:VRNA) highlighted a surprising benefit from a lower [...]

Verona Pharma (VRNA) January 2019 Catalyst: Topline data for RPL554

By |2019-01-22T10:17:48-04:00January 8th, 2019|Categories: Bill Langbein, SanaCurrents, SanaCurrents Probability Sentiment|Tags: , |

SUMMARY Sana Currents assigns a pivotal sentiment that Verona Pharma [...]

Cara Therapeutics (CARA) Q1 2019 Catalyst: Phase III efficacy trial, KALM-2

By |2019-01-22T10:10:46-04:00January 2nd, 2019|Categories: Bill Langbein, SanaCurrents, SanaCurrents Probability Sentiment|Tags: , |

SUMMARY Sana Currents assigns a pivotal sentiment that Cara Therapeutics [...]

ADMA Biologics Believes It Can Resolve CRL Issues Quickly, Spring Review Possible

By |2018-12-28T10:31:02-04:00December 28th, 2018|Categories: Bill Langbein, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents|Tags: , , |

Shares of ADMA Biologics [NASDAQ:ADMA]  fell more than 45% on [...]